Back to Market Feed

Product Information

CARBIDOPA-LEVO ER 50-200 TAB is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1735 per EA under NDC 60219203401. Its NADAC has been published 155 times since Sep 6, 2023.

FDA first approved this application on May 14, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBIDOPA-LEVO ER 50-200 TAB

CARBIDOPA and LEVODOPA
$0.1735per EA

Strength

50; 200 mg/1; mg/1

NDC

60219203401

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARBIDOPA; LEVODOPA

Approval Type

Generic (ANDA)

FDA Application

ANDA076521

FDA Approved

5/14/2004

TE Code

AB

On Market Since

12/21/2022

Pharmacological Classes

Amino Acids
Aromatic
Aromatic Amino Acid

Price Statistics

The NADAC for CARBIDOPA-LEVO ER 50-200 TAB has been published 155 times since Sep 6, 2023, and over the history we have for it it has declined 31.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1735 per EA
All-time high$0.2606 (Nov 15, 2023)
All-time low$0.1551 (May 22, 2024)
52-week high$0.2155
52-week low$0.1676
Median price$0.2052
Average price$0.2041
Largest weekly change+52.4% (Jun 19, 2024)
Weeks tracked155
Tracking sinceSep 6, 2023

Price History

1W

+3.5%

1M

+3.5%

3M

-7.1%

6M

-4.3%

1Y

-19.5%

3Y

N/A

5Y

N/A

All

-31.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CARBIDOPA and LEVODOPA market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

CARBIDOPA-LEVODOPA 10-100 TAB
Generic
00093970101•Teva Pharmaceuticals USA Inc.
$0.0675
per EA
CARBIDOPA-LEVODOPA 10-100 TAB
Generic
00093970105•Teva Pharmaceuticals USA Inc.
$0.0675
per EA
CARBIDOPA-LEVODOPA 10-100 TAB
Generic
31722038101•Camber Pharmaceuticals Inc.
$0.0675
per EA
CARBIDOPA-LEVODOPA 10-100 TAB
Generic
31722038105•Camber Pharmaceuticals Inc.
$0.0675
per EA
CARBIDOPA-LEVODOPA 10-100 TAB
Generic
50228045701•ScieGen Pharmaceuticals Inc.
$0.0675
per EA
CARBIDOPA-LEVODOPA 10-100 TAB
Generic
50228045705•ScieGen Pharmaceuticals Inc.
$0.0675
per EA
CARBIDOPA-LEVODOPA 10-100 TAB
Generic
52817039010•TruPharma LLC
$0.0675
per EA
CARBIDOPA-LEVODOPA 10-100 TAB
Generic
52817039050•TruPharma LLC
$0.0675
per EA
CARBIDOPA-LEVODOPA 10-100 TAB
Generic
59651045601•Aurobindo Pharma Limited
$0.0675
per EA
CARBIDOPA-LEVODOPA 10-100 TAB
Generic
68002010004•American Health Packaging
$0.0675
per EA

Frequently asked questions

What is the NADAC price of CARBIDOPA-LEVO ER 50-200 TAB?

The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO ER 50-200 TAB, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1735 per EA (NDC 60219203401), effective Aug 19, 2026.

How has the price of CARBIDOPA-LEVO ER 50-200 TAB changed over time?

Over the history we have for it, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has declined 31.9%. It has been tracked across 155 weekly CMS publications since Sep 6, 2023.

What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO ER 50-200 TAB?

Since Sep 6, 2023, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has ranged from a low of $0.1551 (May 22, 2024) to a high of $0.2606 (Nov 15, 2023), with a median of $0.2052 per EA.

Are there cheaper alternatives to CARBIDOPA-LEVO ER 50-200 TAB?

No other NADAC-published product currently shares the active ingredient and strength of CARBIDOPA-LEVO ER 50-200 TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CARBIDOPA-LEVO ER 50-200 TAB?

CARBIDOPA-LEVO ER 50-200 TAB (NDC 60219203401) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.